Targeted Radiopharmaceuticals and Imaging
Development Challenges and Opportunities
Series: Drug Development and Pharmaceutical Science;
- Publisher's listprice GBP 199.00
-
89 848 Ft (85 570 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 17 970 Ft off)
- Discounted price 71 879 Ft (68 456 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
89 848 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher RSC
- Date of Publication 4 June 2025
- ISBN 9781837673278
- Binding Hardback
- No. of pages480 pages
- Size 234x156x28.9 mm
- Weight 908 g
- Language English 719
Categories
Short description:
Bringing a cohesive picture on different radiopharmaceutical therapies for cancer treatment, this book will address the challenges in developing and commercialising radiopharmaceuticals.
MoreLong description:
Targeted radiopharmaceutical therapy (RPT) is emerging as an innovative approach for treating a wide range of cancers.
Almost all radionuclides used in RPT emit photons that can be imaged, enabling non-invasive visualization of the therapeutic agent's biodistribution. The remarkable potential of radiopharmaceutical therapy is now being recognized with recent FDA approval of several RPT drugs and a significant number of drug candidates in clinical development.
This book offers a comprehensive perspective on the different technologies and addresses the critical challenges in developing and commercializing radiopharmaceuticals. It covers various topics, from clinical applications to specific radiopharmaceutical biodistribution, dosimetry, and novel targets in oncology. The chapters provide a cohesive picture of the advances in SPECT/CT and PET/CT imaging, clinical trends in targeted therapies utilizing radioisotopes for cancer imaging, and clinical applications of radiotracers within oncology areas. It also delves into the manufacturing technologies and regulatory and supply logistics required to support the development of the next wave of targeted alpha therapies.
This resource is ideal for postgraduates and researchers in drug discovery and development in radionuclide therapy and imaging in cancer, as well as medical professionals engaged in nuclear medicine and radiology.
MoreTable of Contents:
Targeted Radiopharmaceuticals: Clinical Development and Commercial Landscape
Advances in Targeted Radiopharmaceuticals: Challenges and Opportunities
Alpha-particle Emitting Radiopharmaceuticals in Targeted Therapy and Diagnostics: Challenges and Opportunities
Chelator Design and Radiolabeling Chemistry of Radiometals
Dosimetry Methods for Radiopharmaceuticals
Glypican-3 (GPC3) Targeted Radiopharmaceuticals for Treatment of Liver Cancer
Identifying New Molecular Modalities for Radionuclide Therapy Using Macrocyclic Peptide Mimetics
Peptides and Small Radiopharmaceuticals for Molecular Targeting
Antibody Based Radiopharmaceuticals in Clinical Development
Prostate-specific Membrane Antigen Targeted Prostate Imaging and Therapy
Radiotracers for Imaging of Breast Cancer and Targeted Radionuclide Therapy
Neuroendocrine Tumors: Radiopharmaceuticals for Imaging and Therapy
Radiopharmaceuticals for Imaging and Therapy in Neurology
Thyroid Imaging and Radionuclide Therapy
Radiopharmaceuticals for Skeletal Imaging and Therapy
Radiopharmaceuticals in Dermatologic Imaging and Therapy
Targeted Radiopharmaceuticals for Infection Imaging
Manufacturing Challenges and Radiopharmaceutical Application of 18F-labeled Heterocycles for PET Imaging
Quality Considerations in Radiopharmaceuticals
